Filter News
Area of Research
News Topics
- (-) Biomedical (10)
- (-) Fusion (1)
- (-) Polymers (1)
- 3-D Printing/Advanced Manufacturing (9)
- Advanced Reactors (1)
- Artificial Intelligence (4)
- Big Data (2)
- Bioenergy (11)
- Biology (18)
- Biotechnology (5)
- Buildings (2)
- Chemical Sciences (8)
- Climate Change (8)
- Composites (3)
- Computer Science (11)
- Coronavirus (10)
- Critical Materials (1)
- Cybersecurity (1)
- Decarbonization (3)
- Energy Storage (7)
- Environment (16)
- Frontier (1)
- Grid (1)
- High-Performance Computing (6)
- Isotopes (7)
- Machine Learning (2)
- Materials (15)
- Materials Science (16)
- Microscopy (4)
- Molten Salt (1)
- Nanotechnology (11)
- National Security (2)
- Net Zero (1)
- Neutron Science (40)
- Nuclear Energy (3)
- Partnerships (5)
- Physics (8)
- Quantum Science (4)
- Security (2)
- Simulation (4)
- Space Exploration (1)
- Summit (7)
- Sustainable Energy (6)
- Transformational Challenge Reactor (1)
- Transportation (4)
Media Contacts
Scientists at ORNL used their expertise in quantum biology, artificial intelligence and bioengineering to improve how CRISPR Cas9 genome editing tools work on organisms like microbes that can be modified to produce renewable fuels and chemicals.
Scientist-inventors from ORNL will present seven new technologies during the Technology Innovation Showcase on Friday, July 14, from 8 a.m.–4 p.m. at the Joint Institute for Computational Sciences on ORNL’s campus.
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
Ten scientists from the Department of Energy’s Oak Ridge National Laboratory are among the world’s most highly cited researchers, according to a bibliometric analysis conducted by the scientific publication analytics firm Clarivate.
The Department of Energy’s Office of Science has selected five Oak Ridge National Laboratory scientists for Early Career Research Program awards.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.